Can Cencora (COR) Sustain Its Margin Gains While Accepting Slower Revenue Growth?

Cencora, Inc. has already reported fiscal 2026 second-quarter results, posting sales of US$78.36 billion and net income of US$1.64 billion, while slightly raising adjusted EPS guidance but trimming full-year revenue growth expectations to a 4%–6% range. The quarter highlighted improving profitability helped by the OneOncology acquisition and margin expansion, even as U.S. Healthcare Solutions faced headwinds fro…